eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Share:
Send email
Share:
abstract:
Original paper

Indian Brachytherapy Society consensus recommendations for brachytherapy in breast cancer

Daya Nand Sharma
1
,
Ashwini Budrukkar
2
,
Rishabh Kumar
1
,
Tabassum Wadasadawala
2
,
Rajiv Sarin
2
,
Rituraj Upreti
2
,
Ashish Binjola
1
,
Umesh Mahantshetty
3
,
SVS Deo
4
,
Rajendra Badwe
5

  1. Department of Radiation Oncology, AIIMS, New Delhi, India
  2. Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India
  3. Department of Radiation Oncology, Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, India
  4. Department of Surgical Oncology, AIIMS, New Delhi, India
  5. Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
J Contemp Brachytherapy 2024; 16
DOI: https://doi.org/10.5114/jcb.2024.142936
Online publish date: 2024/09/12
View full text Get citation
 
Purpose
This consensus statement of Indian Brachytherapy Society (IBS) aims to generate practical and reproducible guidelines allowing for direct implementation in the Indian scenario.

Material and methods
IBS board of directors appointed a panel of physicians with expertise in breast cancer and, in particular, breast brachytherapy, to develop a consensus statement. First, a literature review on breast brachytherapy was conducted, focusing on randomized trials, prospective studies, and multi-institutional series. Then, guidelines were drafted based on authors’ consensus according to Indian scenario.

Results
IBS advocate accelerated partial breast irradiation (APBI) with brachytherapy following breast conservation surgery (BCS) for suitable groups of patients. Also, IBS recommends brachytherapy as the preferred technique for patients requiring tumor bed boost. Multi-catheter interstitial brachytherapy (MIB) is suitable in most situations, except for a large tumor to breast ratio, and type 2 oncoplasty or higher performed. For best cosmesis, IBS recommends a minimum 3-week gap between chemotherapy and APBI.

Conclusions
Brachytherapy continues to be an established technique for APBI as well as boost in appropriately selected patients with early breast cancer (EBC). As breast brachytherapy is an underutilized therapy in the Indian context, this article will hopefully encourage the readers to use its clinical potential in the suitable groups of patients.

keywords:

breast cancer, brachytherapy, guidelines

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.